Antidiabetics Market Share and Analysis Report 2020: Radiant Insights, Inc

May 25, 2016 Sagar Kadam Healthcare #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

Global antidiabetics market is expected to reach USD 84.13 billion by 2020. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases.

Future commercialization of products currently in the pipeline and the presence of large untapped opportunities in the emerging Asia Pacific and Latin American markets is expected to fuel future market growth.

Insulin was the most revenue generating segment and its market was valued at over USD 20.0 billion in 2013. Insulin is also one of the most lucrative segments of this market. Introduction of new products exhibiting higher efficacy coupled with the presence of favorable government initiatives are some factors attributing to its market attractiveness.

Read Complete Report with TOC @ http://www.radiantinsights.com/research/antidiabetics-market-analysis-by-product-insulin-biguanides-thiazolodinediones-glp-agonists-sulphonylureas-dpp-4-inhibitors-sglt-2-alpha-glucosidase-inhibitors-meglitinides-and-segment-forecasts-to-2020

Further key findings from the study suggest:

Long acting insulin was the leading product segment in 2013 and is expected to grow at the CAGR of over 15.0% during the forecast period. The introduction of advanced products, high prices associated with these products and the phasing out of human insulin are some key factors attributing for its large share.

Rapid uptake of newly approved DPP-4 inhibitors such as Januvia, Nesina and Onglyza on account of their once daily dosage regimens and safety profiles catalyzed the growth of this market.

North America was the most matured antidiabetics market in 2013 accounting for over 43.0% of the market High market penetration of insulin and other antidiabetics and the presence of sophisticated reimbursement framework are expected to drive regional market growth.

Asia Pacific is expected to present manufacturers with lucrative future growth opportunities. Large presence of unmet patient needs and rapidly improving healthcare infrastructure are some factors expected to drive market growth in the region. The market is also expected to be driven by the introduction of cheaper products made available by local manufacturers.

Some key market players of antidiabetics include Sanofi Aventis, Takeda Pharmaceuticals, Eli Lilly, Oramed Pharmaceuticals Inc., Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb, Halozyme Therapeutics and Pfizer.

The market is oligopolistic in nature with few players accounting for over 70% of the market. Extensive R&D investments aimed at new product development and entering new markets via government contracts are the key sustainability strategies adopted by these organizations.

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

Next Generation Cancer Diagnostics Market Trends, Growth and Forecast up to 2015-2022: Radiant Insights, Inc

May 18, 2016 Sagar Kadam Healthcare #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

Global next generation cancer diagnostics market is anticipated to reach USD 20.25 billion by 2022 growing at an estimated CAGR of 32.0% from 2015 to 2022, according to a new report by Radiant Insights Incorporated. Rising incidence of oncology diseases is anticipated to drive the demand for next generation cancer diagnostic tests that are expected to enhance early diagnosis and efficient prognosis of various forms of cancers is a factor expected to positively influence sector growth over the forecast period.

Cancer diagnostics industry is estimated to witness lucrative growth over the forecast period majorly due to rising number of technologically advanced products in the field of companion diagnostics, providing more precise testing results combined with therapeutic monitoring early diagnosis of cancer.

Moreover, there is a significant shift observed from traditional laboratory testing to rapid point of care testing, which fuels growth in the market owing to expected commercialization of technologically advanced range of products including diagnostic kits, instruments, and reagents.

Read Complete Report with TOC @ http://www.radiantinsights.com/research/next-generation-cancer-diagnostics-market

Furthermore, supportive government initiatives in order to increase the number of research projects with respect to oncology and preventative diagnosis is expected to be attributive for growth in this sector overthe coming years. Additionally, application of tumor diagnostics in epigenetic analysis and CTC enumeration for monitoring tumorigenesis is expected to support projected growth over the forecast period.

Further key findings from the report suggest:

RT-PCR & multiplexing accounted for the largest share of the market in 2014 with respect to technologies because of the presence of a wide product portfolio that caters to a number of applications in oncology R&D.

Next generation sequencing solutions for use in cancer diagnostics are expected to witness lucrative growth in revenue over the forecast period owing to the considerable number of advantages the technology offers over its counterpart segment i.e. microarrays. Introduction of novel sequencing platforms and growth oriented initiatives taken by major market participants are other key factors expected to fuel segment growth.

In January 2016, Illumina launched its MiniSeq system for the sequencing, which provides complete sequencing solution in order to obtain quicker results because of onboard data analysis for numerous assays and workflow with easy-to-use library-to-results. Such strategic initiatives taken by major market entities are also expected to drive this segment further over the forecast period.

Development and expected commercialization of a number of companion diagnostics is a key factor attributive of anticipated substantial growth in demand and progress of the segment over the next seven years owing to rising sector penetration in this segment for use with therapeutics and novel pharmaceuticals as adjunct in monitoring tumor eradication.

Dominant industry participants to produce non-small cell lung cancer diagnostic tests anticipate lung cancer to witness substantial growth in market demand because of product development operations carried out.

Application of oncology diagnostics in biomarker discovery by transcription regulation is expected to drive industry with potential growth avenues as it subsequently proves helpful in drug designing and identification of novel targets for tumor eradication

North America held the largest share with respect to revenue generation in 2014 due to simultaneous development of next generation sequencing, personalized medicine and companion diagnostics in the region. Furthermore, high R&D investment as well as availability of technologically advanced healthcare research framework, is expected to serve as a critical factor for the North American region to register considerable growth over the forecast period.

Presence of significant developments by China and Japan for technological integration, and the development of healthcare infrastructure have poised the Asia Pacific oncology diagnostics market to witness lucrative opportunities of growth throughout the forecast period. Moreover, enhancements of clinical development frameworks in these economies to enable clinical research outsourcing as an effect of the availability of target population is a growth rendering driver in this region.

Key players contributing significantly to the next generation cancer diagnostics market are Novartis AG, Cepheid, Roche Holdings AG, Perkin Elmer Inc., Sysmex Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc., Philips Electronics NV, Agilent Technologies Inc., Illumina Inc., Genomic Health Inc. Qiagen, Johnson & Johnson, Hologic Inc., Myriad Genetics Inc., Almac Group Limited, Opko Health Inc., and GE Healthcare,

These entities are involved in collaborations with oncology research organizations and clinical research institutes in order to gain access in the oligopolistic market.

About Us

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

Hip Replacement Implants Market Analysis, Market Size, Competitive Trends: Radiant Insights, Inc

May 17, 2016 Sagar Kadam Healthcare #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

2015 Global Hip Replacement Implants Industry Report is a professional and in-depth research report on the world’s major regional market conditions of the Hip Replacement Implants industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report firstly introduced the Hip Replacement Implants basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on.

Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Browse Full Report With TOC @ http://www.radiantinsights.com/research/global-hip-replacement-implants-market-research-report-2015

The report includes six parts, dealing with:

1.) basic information;

2.) the Asia Hip Replacement Implants industry;

3.) the North American Hip Replacement Implants industry;

4.) the European Hip Replacement Implants industry;

5.) market entry and investment feasibility; and

6.) the report conclusion.

About Us

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

Intraocular Lenses Market Growth, Competitive Scenario & Forecasts Report Up To 2015: Radiant Insights, Inc

May 12, 2016 Sagar Kadam Healthcare #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

2015 Global Intraocular Lenses Industry Report is a professional and in-depth research report on the world’s major regional market conditions of the Intraocular Lenses industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report firstly introduced the Intraocular Lenses basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on.

Browse Full Report With TOC @ http://www.radiantinsights.com/research/global-intraocular-lenses-market-research-report-2015

The report includes six parts, dealing with:

1.) basic information;

2.) the Asia Intraocular Lenses industry;

3.) the North American Intraocular Lenses industry;

4.) the European Intraocular Lenses industry;

5.) market entry and investment feasibility; and

6.) the report conclusion.

About Us

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

Research Study – China Sewage Treatment Market Forecasts and Growth Study to 2013-2017 by Radiant Insights, Inc

April 28, 2016 Sagar Kadam Healthcare #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

As of the end of 2012, the number of sewage treatment plants in cities and counties in China was 3,340; sewage treatment capacity was approximately 142 million cubic meters / day, showing an increase of 6 million cubic meters / day compared with the end of 2011.

There are 648 cities establishing sewage treatment plants, accounting for 98.5% of the total number of cities; the cumulative number of sewage treatment plants is 1,947 (increased by 106 compared with the end of 2011); sewage treatment capacity is 117 million cubic meters / day (increased by 4.5 million cubic meters / day).

Nine cities have not yet built sewage treatment plants, including Aershsan in Inner Mongolia Autonomous Region, Shangzhi, Wuchang, Mishan, Tieli, and Hailun in Heilongjiang Province, Lincang in Yunnan Province, Xigaze Tibet Autonomous Region, and Wujiaqu City in Xinjiang.

For more information kindly visit: http://www.radiantinsights.com/research/development-research-and-investment-value-of-sewage-treatment-industry-in-china-2013-2017

There are 1,254 counties establishing sewage treatment plants, accounting for 77.7% of the total number of county, increasing by 7.2% over the end of 2011. The cumulative number of sewage treatment plant is 1,393; sewage treatment capacity is 24.21 million cubic meters / day. 22 provinces, autonomous regions and municipalities in China have achieved the goal of “each county (city) has a sewage treatment plant”.

With the strengthening of environmental protection, as well as the enhancement of pollutants treatment efforts, the national investment in environment is increasing year by year; sewage treatment industry usher in a peak period of development; the overall scale is growing at a high speed.

About Us

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

Blood Glucose Meter Market Analysis, Market Size, Competitive Trends: Radiant Insights, Inc

April 27, 2016 Sagar Kadam Healthcare #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

Amid the global economy growth, the number of consumers with diabetes is rising annually in several countries and regions as result of unhealthy diets with high sugar and calorie intakes. Having a blood glucose meter is evidenced to help diabetes patients effectively control blood glucose levels, thereby reducing the risk of complications associated with diabetes.

This report provides an overview of invasive and non-invasive blood glucose meters and market outlook and the relative R&D strength analysis of top 30 companies; examines strategic and patent deployments of several established players in the industry such as Dexcom, Medtronic, Abbott, Baxter and Roche Diagnostics.

View Full Report with TOC @ http://www.radiantinsights.com/research/blood-glucose-meter-technology-business-opportunity-and-patent-analysis

List of Topics

Overview of the blood glucose meters, including invasive and non-invasive types

Major technology fields and sectors identified using the data mining technique; also included are top 30 assignees and their R&D strength ranking

A brief outlook for the sales volume and value of the worldwide blood glucose meter market from 2015 to 2019

Worldwide blood glucose meter market share by sector, and by field type

Analysis of 30 blood glucose meter assignees’ deployment in 28 corresponding technology fields and also included is matrix analysis of 10 most important blood glucose meter patents

List of Tables

Table 1: Comparison of Invasive and Non-invasive Blood Glucose Meters

Table 2: Key Technology Fields Identified by Text Mining for Blood Glucose Meters

Table 3: R&D Strength Ranking of Top 30 Assignees in the Field of Blood Glucose Meters

Table 4: Blood Glucose Meter Assignees’ Technology Field Deployment Analysis

Table 5: Blood Glucose Meter Assignees’ Technology Field Deployment Analysis (continued)

Table 6: Top 10 Assignees of Blood Glucose Meters

Table 7: Matrix Analysis of 10 Most Important Blood Glucose Meter Patents

List of Figures

Figure 1: Illustration of Blood Glucose Meters

Figure 2: Search Flow for Blood Glucose Meter Patents

Figure 3: Blood Glucose Meters’ Distribution Share by Sector

Figure 4: Blood Glucose Meters’ Distribution Share by Field Type

About Us

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

China Orthopedic Device Market 2013-2017: Application Analysis, Competitive Insights and Forecasts Report, 2013-2017: Radiant Insights, Inc

April 26, 2016 Sagar Kadam Healthcare #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

Research and Development Forecast of China Orthopedic Device Market, 2013-2017 firstly, introduces the development history of China orthopedic device industry and sums up the industrial related policies and regulations.

Then, it further analyzes the market scale, market characteristics and competition pattern of orthopedics device. Finally, it forecasts the future development of China orthopedics device, which can provide decision reference for investment in the field.

At present, the market pattern of China orthopedics device is similar to the pattern of preparation market. The high-end market and class 3 hospitals are mainly occupied by foreign-funded enterprises, while local enterprises are mainly the low-end market and class 2 hospitals.

For more information kindly visit: http://www.radiantinsights.com/research/research-and-development-forecast-of-china-orthopedic-device-market-2013-2017

However, foreign-funded enterprises and local enterprises are expanding to the first-tier and second-tier cities, competing for positions. In order to accelerate to expand the China market, for foreign-funded enterprises, acquisition of China high quality enterprises of such field has become the convenient way.

Benefiting from the improvement of the national income level, the coming of an aging population and the increase in the proportion of medical reimbursement etc., the market demand of orthopedics industry has got effective release in recent years in China.

Since 2006, the compound annual growth rate of China orthopedics device market scale has been about 20%. In 2012, the market scale of China orthopedic device was about CNY 9.85 billion, with 270,000 cases of joint replacement, 420,000 cases of spinal device, millions cases of trauma device and 200,000-250,000 cases of dental implant. Among them, trauma products, spinal products and joint products are top 3 segment products.

About Us

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

China Sewage Treatment Market Analysis, Market Size, Competitive Trends: Radiant Insights, Inc

April 25, 2016 Sagar Kadam Healthcare #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

View Full Report with TOC @ http://www.radiantinsights.com/research/china-sewage-treatment-industry-report-2013-2017

About Us

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

New Study – EHealth Market Analysis Research Report: Radiant Insights, Inc

April 22, 2016 Sagar Kadam Healthcare, Uncategorized #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

In the face of an aging population and the rise of chronic diseases, governments around the world have been looking for solutions to reducing health care expenditures while maintaining medical service quality. eHealth, which provides electronic, digital, and automated medical services, is one of such solutions.

This report provides an overview of eHealth applications and examines the relative R&D intensity and patent deployments of several established players in the industry, including Bosch, Medtronic, General Electric, Philips, Siemens, and Honeywell.

List Of Topics

Overview of major eHealth applications: e-prescribing, electronic healthcare records, health information systems, mobile health, and telehealth

View Full Report with TOC @ http://www.radiantinsights.com/research/ehealth-applications-and-major-vendors-and-patent-deployment

Data mining analysis which pinpoints major technology fields and sectors of vendors’ eHealth patents; also included are top 30 assignees and their R&D intensity

Analysis of established vendors’ patent deployment strategies, including technology fields and patent generality index analysis

List of Tables

Table 1: Comparison of Different eHealth Services

Table 2: Key Technology Fields Identified by Text Mining for eHealth Patents

Table 3: R&D Intensity Ranking of Top 30 Assignees in the Field of eHealth

Table 4: eHealth Assignees’ Technology Field Deployment Analysis

Table 5: Top 10 eHealth Patents in Terms of Citations and Patent Families

Table 6: Matrix Analysis of 10 Most Important eHealth Patents

List of Figures

Figure 1: Illustration of eHealth Services

Figure 2: Search Flow for eHealth Patents

Figure 3: Distribution Share of eHealth Patents by Sector

Figure 4: Distribution Share of eHealth Patents by Field”

About Us

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

China Elder Care Market Size, Survey Report to 2013-2017: Radiant Insights, Inc

April 21, 2016 Sagar Kadam Healthcare #MarketResearch, #IndustryAnalysis, #MarketSize, #MarketGrowth, #MarketShare, #Trends, #Forecast, #MarketResearchReports, #RadiantInsights

In 2012, China’s ageing population accounted for 14.3% with the number of 193 million. It is estimated that this number will exceed 220 million by 2015 and exceed 400 million in 2027.

In nearly half a century in the future, China’s ageing population will always show a rapid growth trend. Huge ageing population and the ever-increasing trend in the next few decades decides that the elder consumer group will support a huge market for elders.

China’s elder care organizations have gained rapid development in recent nearly 30 years, especially, the number of beds in the elder care organizations increased rapidly. According to the bulletin of Committee on Ageing of National Bureau of Statistics, in the end of 2012, there were 42,000 elder care service organizations with the bed number of 3.81 million in China.

For more information kindly visit: http://www.radiantinsights.com/research/research-and-development-trend-of-china-s-elder-care-industry-2013-2017

This number is far from the target of 30 beds for per thousand elders. “Line up” has become a popular issue for the elders.

The development of elder care industry does not catch up with the intensified ageing. According to the surveys of China National Committee on Ageing in 13 provinces and cities, China’s aging industry has involved elder care services, healthcare, tourism, education, real estate and other areas, but most of the enterprises are in small and medium scale, the strength is not strong, and the industry chain is not formed; some related industries and large investors have not entered this industry.

The existing elder care service organizations and facilities are still far from meeting the market demands, and the elder care service industry does not form a certain market scale.

“Research and Development Trend of China’s Elder Care Industry, 2013-2017” mainly analyzes the status quo of domestic market and business performance of key enterprises in the elder care industry, and also conducts analysis and forecast to the future development; these information can provide decision reference for enterprises to understand and invest this industry.

About Us

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://sagarkadam.kinja.com/

	Michael Verrett on Industrial Machinery Manufactu…
	Michael Verrett on Construction Machinery Produce…
	Michael Verrett on Construction Machinery Produce…
	Global Radiology Inf… on Global Radiology Information S…
	bitechmedical on Global Stationary Oxygen Conce…